← Open Payments lookup

ERIKA SCANLON: Open Payments

NPI 1366712010 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$290 in 11 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $586 · 2025 $290

Food & beverage: $290
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.2$53
Alkermes, Inc.2$48
E.R. Squibb & Sons, L.L.C.2$48
Axsome Therapeutics, Inc.2$45
ABBVIE INC.1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$32
Vanda Pharmaceuticals Inc.1$31

Products named: COBENFY, Auvelity, VRAYLAR, CAPLYTA, FANAPT, VIVITROL, REXULTI, ABILIFY MAINTENA.

Industry payments across MA — which companies pay providers there.